159
Participants
Start Date
March 26, 2019
Primary Completion Date
November 9, 2020
Study Completion Date
September 30, 2022
M7824
Participants received an intravenous infusion of 1200 milligrams (mg) M7824 once every 2 weeks until confirmed disease progression, death, unacceptable toxicity or study withdrawal.
Chang Gung Memorial Hospital, Linkou, Linkou District
National Cheng Kung University Hospital, Tainan City
Hospital Universitari Vall d'Hebron - Dept of Oncology, Barcelona
Seoul National University Bundang Hospital, Seongnam-si
Istituto Clinico Humanitas, Rozzano
Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Milan
Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Hospital Universitario HM Madrid Sanchinarro - Servicio de Oncologia, Madrid
Mayo Clinic in Florida - Department of Neurology, Jacksonville
Groupe Hospitalier Sud - Hôpital Haut Lévêque - Service Hepato Gastroentérologie Oncologie Digest, Pessac
Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi - Unita' Operativa di Pediatria, Bologna
ICO - Site René Gauducheau, Saint-Herblain
Mayo Clinic - Rochester, Rochester
MD Anderson Cancer Center - Unit, Houston
Mayo Clinic Arizona, Scottsdale
UCSF Mount Zion Medical Ctr, San Francisco
Institut Gustave Roussy, Villejuif
Peking University Cancer Hospital, Beijing
Affiliated Tumor Hospital of Harbin Medical University, Harbin
H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa
Policlinico Universitario Agostino Gemelli - UOC Oncologia Medica, Roma
National Cancer Center Hospital - Dept of Hepatobiliary and Pancreatic Oncology, Chūōku
National Cancer Center Hospital East, Kashiwa-shi
Kyorin University Hospital - Dept of Oncology, Mitaka-shi
Kindai University Hospital - Dept of Gastroenterology, Osakasayama-shi
Kanagawa Cancer Center, Yokohama
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Hospital de la Santa Creu i Sant Pau, Barcelona
National Taiwan University Hospital, Taipei
St James's University Hospital - Dept of Oncology, Leeds
Merck KGaA, Darmstadt, Germany
INDUSTRY
EMD Serono Research & Development Institute, Inc.
INDUSTRY